Dear Colleagues,

There is a rapid progress in the development of nanotechnologies and nanomaterials, especially their use as nanocarriers for drug delivery. The number of papers related to nanomaterials and drug delivery has increased from no more than 20 in 2000 to more than 6 thousand in the last year. Their small size allows the penetration of drugs into cells in an easier manner. However, these nanomaterials can also facilitate penetration trough more complex systems such as the skin, eyes or the blood–brain barrier or increase the oral bioavailability of drugs with poor solubility, poor permeability, and/or poor stability in the gastrointestinal environment.

Nanocarriers may be tailored to control drug release and/or increase selective cell targeting, cellular uptake, drug solubility, and circulation time in order to maximize the therapeutic effects of drugs and minimize their side effects.

The kind of nanomaterials used with the objective of allowing drug delivery include nanoparticles in a wide variety as nanospheres, micelles, solid lipid nanoparticles, nanoliposomes, dendrimers, magnetic nanoparticles, and nanocapsules.

Nanomaterials for the delivery of anticancer drugs are one of the most studied but there are also other applications, such as the treatment of neurodegenerative and cardiovascular diseases, inflammatory disorders among others.

This Special Issue will cover research in this area with different types of nanomaterials and for different therapeutic purposes.

Prof. Dr. Maria Pilar Vinardell
Prof. Dr. Montse Mitjans Arnal
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nanocarriers
• drug delivery
• therapy
• nanovesicles
• safety